US 7691878
Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
granted A61PA61P1/00
Quick answer
US patent 7691878 (Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists) held by Theravance, Inc. expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/00